Atrium Therapeutics, Inc. (RNA)

CIK 2093101 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Atrium Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 2, 20268-K0001193125-26-442601
Oct 27, 20268-K0001193125-26-432949
Oct 9, 20268-K/A0001193125-26-418417
Oct 8, 20268-K0001193125-26-417402
Sep 22, 202640001193125-26-397936
Sep 22, 202640001193125-26-397941
Sep 22, 202640001193125-26-397951
Sep 22, 202640001193125-26-397971
Sep 22, 202640001193125-26-397967
Sep 22, 202640001193125-26-397944
Sep 22, 202640001193125-26-397948
Sep 22, 202640001193125-26-397955
Aug 14, 2026SCHEDULE 13G/A0000080255-26-000590
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000917
Aug 14, 2026SCHEDULE 13G0000902664-26-003500
Aug 13, 20268-K0001193125-26-349482
Aug 13, 202610-Q0001193125-26-349488
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002192
Jul 14, 20268-K0001193125-26-303393
May 15, 2026SCHEDULE 13G0001346824-26-000145
May 14, 202610-Q0001193125-26-224243
May 14, 20268-K0001193125-26-224238
Apr 27, 2026SCHEDULE 13G0002012383-26-001673
Apr 22, 202640001193125-26-170914
Apr 22, 202640001193125-26-170960